A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats

Pain

Volumn 76, Issue 1-2, 1998, Pages 151-157

  Malcangio, Marzia ^a   Tomlinson, David R ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

( )Baclofen; (+)MK 801; Diabetes; Mechanical hyperalgesia; Morphine; RP 67580

Indexed keywords

BACLOFEN; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROKININ; OPIATE RECEPTOR; SUBSTANCE P ANTAGONIST;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; GABAERGIC TRANSMISSION; HEAT SENSITIVITY; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; BACLOFEN; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIZOCILPINE MALEATE; GABA AGONISTS; HYPERALGESIA; INDOLES; MALE; PHYSICAL STIMULATION; PRESSURE; RATS; RATS, WISTAR; RECEPTORS, GABA-B; RECEPTORS, NEUROKININ-1; SCIATIC NERVE; SPINAL CORD; SUBSTANCE P;

EID: 0031775954     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00037-2     Document Type: Article

References (49)

1. Ahlgren S.C., Levine J.D. Increased responsiveness of sensory neurons in the saphenous nerve of streptozotocin-diabetic rats. J. Neurophysiol. 68:1992;2077-2085.
2. Ahlgren S.C., Levine J.D. Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained. Brain Res. 616:1993;171-175.
3. Apfel S.C., Arezzo J.C., Brownlee M., Federoff H., Kessler J.A. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634:1994;7-12.
4. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in the rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
5. Besson J.-M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67:1987;67-186.
6. Britland S.T., Young R.J., Sharma A.K., Clarke B.F. Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology. Pain. 48:1992;361-370.
7. Brewster W.J., Fernyhough P., Diemel L.T., Mohiuddin L., Tomlinson D.R. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci. 17:1994;321-325.
8. Brown M.J., Sumner A.J., Greene D.A., Diamond S.M., Asbury A.K. Distal neuropathy in experimental diabetes mellitus. Ann. Neurol. 8:1980;168-178.
9. Burchiel K.J., Russell L.C., Lee R.P., Sima A.A.F. Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. Diabetes. 34:1985;1210-1213.
10. Calcutt N.A., Malmberg A.B., Yaksh T.L. Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. Pain. 58:1994;413-420.
11. Calcutt N.A., Jorge M.C., Yaksh T.L., Chaplan S.R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effect of insulin, aldose reductase inhibition and lidocaine. Pain. 68:1996;293-299.
12. B receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Res. 679:1995;289-297.
13. Chu P.C., Lin M.T., Shian L.R., Leu S.Y. Alterations in physiological functions and in brain monoamine content in streptozotocin-diabetic rats. Diabetes. 35:1986;481-485.
14. Courteix, C., Eschalier, A. and Lavarenne, J., Streptozotocin-induced diabetic rats: behavioural evidence for a model of chronic pain, Pain, 53 (1993a) 81-88.
15. 1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats, Eur. J. Pharmacol., 241 (1993b) 267-270.
16. Courteix C., Bardin M., Chantelauze C., Lavarenne J., Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain. 57:1994;153-160.
17. Davies S.N., Lodge D. Evidence for involvement of N-methyl-D-aspartate receptors in wind-up of class 2 neurones in the dorsal horn of the rat. Brain Res. 424:1987;402-406.
18. Davies J., Watkins J.C. Role of excitatory amino acid receptors in mono- and polysynaptic excitation in the cat spinal cord. Exp. Brain Res. 49:1983;280-290.
19. DeLeo J.A., Coombs D.W., Willenbring S., Colburn R.W., Fromm C., Wagner R., Twitchell B.B. Characterization of a neuropathic pain model: sciatic cryoneurolysis in the rat. Pain. 56:1994;9-16.
20. Dickenson A.H., Sullivan A.F. Differential effects of excitatory amino acids antagonists on dorsal horn nociceptive neurones in the rat. Brain Res. 506:1990;31-39.
21. Diemel L.T., Stevens E.J., Willars G.B., Tomlinson D.R. Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition. Neurosci. Lett. 137:1992;253-256.
22. Ellis T.M., Atkinson M.A. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nature Med. 2:1996;148-153.
23. Forman L.J., Estilow S., Lewin M., Vasilenko P. Streptozotocin-diabetes alters immunoreactive β endorphin levels and pain perception after 8 wk in female rats. Diabetes. 35:1986;1309-1313.
24. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.-F., Blanchard J.-C., Laduron P.M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. USA. 88:1991;10208-10212.
25. Garrett N.E., Malcangio M., Dewhurst M., Tomlinson D.R. α-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci. Lett. 222:1997;191-194.
26. Garrison C.G., Dougherty P.M., Carlton S.M. Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801-treated rats. Brain Res. 607:1993;205-214.
27. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
28. Jaffey P.B., Gelman B.B. Increased vulnerability to demyelination in streptozotocin diabetic rats. J. Comp. Neurol. 373:1996;55-61.
29. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
30. 1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat. Br. J. Pharmacol. 109:1993;713-718.
31. Lee J.H., McCarty R. Glycemic control of pain threshold in diabetic and control rats. Physiol. Behav. 47:1990;225-230.
32. A receptor activation, inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro. J. Pharmacol. Exp. Ther. 266:1993;1490-1496.
33. Malcangio M., Bowery N.G. GABA and its receptors in the spinal cord. Trends Pharmacol. 17:1996;457-462.
34. 1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats. Neurosci. Lett. 161:1993;45-48.
35. Max M.B., Culnane M., Schafer S.C., Gracely L.H., Walthers D.J., Smoller B., Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 37:1987;589-596.
36. 2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain. 63:1995;33-37.
37. Rains C., Bryson H.M. Topical capsaicin. A review of its pharmacological properties and therapeutic potentials in postherpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging. 7:1995;317-328.
38. Robinson J.P., Willars G.B., Tomlinson D.R., Keen P. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Brain Res. 426:1987;339-348.
39. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
40. Simon G.T., Dewey W.L. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J. Pharmacol. Exp. Ther. 218:1981;318-323.
41. Solimena M., De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci. 14:1991;452-457.
42. Thomas, P.K. and Tomlinson, D.R., Diabetic and hypoglycemic neuropathy. In: P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low and J.F. Poduslo (Eds.), Peripheral Neuropathy, W.B. Saunders, Philadelphia, PA, 1993, pp. 1219-1250.
43. Ueno Y., Koike H., Annoh S., Nishio S. Effects of beraprost sodium, a prostacyclin analogue, on tail flick response in two models of diabetic-neuropathy in rats and its mechanism. Life Sci. 59:1997;105-110.
44. Willars G.B., Calcutt N.A., Compton A.M., Tomlinson D.R., Keen P.J. Substance P levels in peripheral nerves, skin, atrial myocardium and gastrointestinal tract of rats with long term diabetes mellitus. Effect of aldose reductase inhibition. J. Neurol. Sci. 91:1989;153-164.
45. Willenbring S., DeLeo J.A., Coombs D.W. Differential behavioral outcomes in the sciatic cryoneurolysis model of neuropathic pain in rats. Pain. 58:1994;135-140.
46. Wolinsky T.D., Abrahamsen G.C., Carr K.D. Diabetes alters μ and κ opioid binding in rat brain regions: comparison with effects of food restriction. Brain Res. 738:1996;167-171.
47. Wuarin-Bierman L., Zahnd G.R., Kaufman F., Burcklen L., Adler J. Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia. 30:1987;653-658.
48. Yaksh T.L., Pogrel J.W., Lee Y.W., Chaplan S.R. Reversal of nerve ligation-induced allodynia by spinal alfa-2-adrenoceptor agonists. J. Pharmacol. Exp. Ther. 272:1995;207-214.
49. Yamamoto T., Yaksh T.L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic neuropathy. Neurosci. Lett. 135:1992;67-70.